Found: 8
Select item for more details and to access through your institution.
First-in-Humans Evaluation of Safety and Dosimetry of <sup>64</sup>Cu-LLP2A for PET Imaging.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 320, doi. 10.2967/jnumed.122.264349
- By:
- Publication type:
- Article
First-in-Human Evaluation of Safety and Dosimetry of <sup>64</sup>Cu-LLP2A for PET Imaging.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264349
- By:
- Publication type:
- Article
First-in-Human Evaluation of Safety and Dosimetry of <sup>64</sup>Cu-LLP2A for PET Imaging.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.264349
- By:
- Publication type:
- Article
The Role of Exploratory Investigational New Drugs for Translating Radiopharmaceuticals into First-in-Human Studies.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 4, p. 497, doi. 10.2967/jnumed.114.146472
- By:
- Publication type:
- Article
Logistical, technical, and radiation safety aspects of establishing a radiopharmaceutical therapy program: A case in Lutetium‐177 prostate‐specific membrane antigen (PSMA) therapy.
- Published in:
- Journal of Applied Clinical Medical Physics, 2023, v. 24, n. 4, p. 1, doi. 10.1002/acm2.13899
- By:
- Publication type:
- Article
Rebuilding Representative Democracy.
- Published in:
- 2016
- By:
- Publication type:
- Book Review
[<sup>89</sup>Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
[Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer.
- Published in:
- Molecular Imaging & Biology, 2016, v. 18, n. 6, p. 952, doi. 10.1007/s11307-016-0951-z
- By:
- Publication type:
- Article